Hester Biosciences Q4 net up 27 percent

Published On 2018-05-17 03:45 GMT   |   Update On 2018-05-17 03:45 GMT

New Delhi: Hester Biosciences reported 26.72 percent rise in standalone net profit to Rs 9.01 crore for the March quarter, 2017-18.


It had posted the net profit of Rs 7.11 crore for the January-March period of 2016-17, Hester Biosciences said in a filing to BSE.


The standalone net sales of the company rose to Rs 37.48 crore for the fourth quarter of last fiscal as against Rs 35.59 crore in the year-ago period.


For the entire 2017-18, the standalone net profit of Hester rose to Rs 30.55 crore. It was Rs 24.94 crore in the preceding fiscal.


Its net sales rose to Rs 135.25 crore for the fiscal ended March 2018. It was Rs 125.57 crore in 2016-17.


Total dividend for 2017-18 will be Rs 10 per equity share as against Rs 5.30 per equity share in 2016-17, the company said.

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News